Skip to main content
. 2020 Apr 20;11(4):253. doi: 10.1038/s41419-020-2449-5

Fig. 6. Dual inhibition of FAO and glycolysis improves survival in a orthotopic GBM mouse model.

Fig. 6

Etomoxir (40 mg/kg) and/or 2-DG (500 mg/kg) were administered via intraperitoneal (i.p.) injection 5 days a week. a, b Mice were imaged and tumors measured using MRI 10–12 days following MES83 tumor implant. Data represents mean ± SD. **p < 0.005. c Kaplan–Meier survival plot and statistical analysis in mice treated with the indicated agents.